Universal Vision Biotechnology Co., Ltd. (TPEX: 3218)

Market Cap	18.43B
Revenue (ttm)	4.17B
Net Income (ttm)	1.10B
Shares Out	84.72M
EPS (ttm)	12.97
PE Ratio	16.77
Forward PE	15.56
Dividend	7.00 (3.29%)
Ex-Dividend Date	Apr 18, 2024

Volume	401,455
Open	215.00
Previous Close	212.50
Day's Range	215.00 - 221.00
52-Week Range	208.00 - 346.50
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Universal Vision Biotechnology

Universal Vision Biotechnology Co., Ltd. operates a chain of eye care clinics in Taiwan and China. The company offers optical devices, glasses, lens, and vision aid products. It is also involved in leasing of medical devices. In addition, the company offers hospital management, optometric, and technical consultancy services, as well as provides medical and scientific prescription eyeglasses. Further, it offers sunglasses, fashionable and reading glasses, and progressive lenses for presbyopia. Additionally, the company provides contact lenses fo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 401
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3218

Financial Performance

In 2023, Universal Vision Biotechnology's revenue was 4.08 billion, an increase of 16.83% compared to the previous year's 3.49 billion. Earnings were 1.05 billion, an increase of 22.88%.